申请人:Sanofi-Synthelabo
公开号:US06235791B1
公开(公告)日:2001-05-22
The present invention relates to the use of compounds capable of displacing tritiated cis-N-cyclohexyl-N-ethyl [3-(3-chloro-4-cyclohexylphenyl)-allyl]amine from its receptors for the preparation of pharmaceutical compositions intended to combat cell proliferation.
本发明涉及利用能够将氚标记的顺式-N-环己基-N-乙基[3-(3-氯-4-环己基苯基)-烯基]胺从其受体上置换的化合物,用于制备旨在抑制细胞增殖的药物组合物。